VC  Longwood Fund

     Office Locations:

The Prudential Tower
800 Boylston Street, Suite 1555
Boston, MA 02199
Phone: 617-351-2590



  • Early
  • Seed



  • Life Sciences & Healthcare



    Longwood Fund is a healthcare venture capital firm that founds, manages, and builds biotechnology companies. Longwood's mission is to identify technologies and to found companies that will advance new therapeutics that can not only make a difference in the lives of patients worldwide, but also create significant value for investors. Longwood's portfolio includes Alnara Pharmaceuticals, Inc., which was acquired by Eli Lilly in 2010 for $180 million cash upfront and a $200 million earn-out, and Verastem, Inc., a biotechnology company focused on discovering and developing novel drugs that selectively target cancer stem cells. Members of the Longwood team have founded and built several successful biotechnology companies including Momenta Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Sirtris Pharmaceuticals, Inc., and Alnara Pharmaceuticals, Inc. The firm's first fund, Longwood Founders Fund, L.P., was capped at $85 million when it closed December of 2010. Members of the Longwood team have co-founded and run biotechs worth a combined ~$60 billion, holding roles of CEO, Chairperson, and Lead VC.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Aleks Radovic-Moreno PhD Partner
    Annalisa D'Andrea PhD Venture Partner
    Christoph Westphal M.D., Ph.D. Co-Founder and General Partner
    David Donabedian PhD Operating Partner
    David Steinberg MBA General Partner


    Recent Funding Events (trailing 12 months):










      Series A


    Portfolio companies include:


    Recent News: